Published in Oncogene on September 10, 2007
MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer (2013) 3.60
Mechanisms of chromosomal instability. Curr Biol (2010) 3.21
The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol (2010) 3.08
Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases. Cancer Cell (2009) 2.28
Glucose metabolism attenuates p53 and Puma-dependent cell death upon growth factor deprivation. J Biol Chem (2008) 1.58
Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma. Cancer Cell (2012) 1.54
Mdm2 promotes genetic instability and transformation independent of p53. Mol Cell Biol (2008) 1.25
Mouse models of p53 functions. Cold Spring Harb Perspect Biol (2009) 1.23
MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival. Cancer Res (2010) 1.16
miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma. J Invest Dermatol (2013) 1.15
Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivo. Neoplasia (2009) 1.07
Tied up in loops: positive and negative autoregulation of p53. Cold Spring Harb Perspect Biol (2009) 1.05
Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability. Oncotarget (2014) 1.05
The Mdm network and its regulation of p53 activities: a rheostat of cancer risk. Hum Mutat (2014) 0.97
Genomic instability and colon carcinogenesis: from the perspective of genes. Front Oncol (2013) 0.97
MdmX regulates transformation and chromosomal stability in p53-deficient cells. Cell Cycle (2008) 0.95
Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer. RNA (2014) 0.92
Inactivation of p53 is insufficient to allow B cells and B-cell lymphomas to survive without Dicer. Cancer Res (2014) 0.91
Mdmx promotes genomic instability independent of p53 and Mdm2. Oncogene (2014) 0.91
A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis. Oncogene (2010) 0.90
The Many Faces of MDM2 Binding Partners. Genes Cancer (2012) 0.90
Aging mice have increased chromosome instability that is exacerbated by elevated Mdm2 expression. Oncogene (2011) 0.89
Pharmacologically Increasing Mdm2 Inhibits DNA Repair and Cooperates with Genotoxic Agents to Kill p53-Inactivated Ovarian Cancer Cells. Mol Cancer Res (2015) 0.88
Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis. Cell Death Differ (2012) 0.87
Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies. Cancer Res (2015) 0.86
Histone deacetylase inhibition reveals a tumor-suppressive function of MYC-regulated miRNA in breast and lung carcinoma. Cell Death Differ (2016) 0.85
Splicing up mdm2 for cancer proteome diversity. Genes Cancer (2012) 0.85
p37Ing1b regulates B-cell proliferation and cooperates with p53 to suppress diffuse large B-cell lymphomagenesis. Cancer Res (2008) 0.83
It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53. Genes Cancer (2012) 0.83
Protecting the genome from mdm2 and mdmx. Genes Cancer (2012) 0.79
Mdm2 overexpression and p73 loss exacerbate genomic instability and dampen apoptosis, resulting in B-cell lymphoma. Oncogene (2015) 0.77
Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age. Oncotarget (2015) 0.76
Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis. Transl Cancer Res (2016) 0.76
BCL-W has a fundamental role in B cell survival and lymphomagenesis. J Clin Invest (2017) 0.75
Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture. Sci Rep (2017) 0.75
Mdm2 is required for survival and growth of p53-deficient cancer cells. Cancer Res (2017) 0.75
Role of MDM2 and MDMX in DNA repair. J Mol Cell Biol (2016) 0.75
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Regulation of p53 stability by Mdm2. Nature (1997) 18.20
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev (1998) 9.03
Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science (2000) 8.56
Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J (1998) 3.12
Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood (1999) 2.95
Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol Cell Biol (2001) 2.76
DNA copy number losses in human neoplasms. Am J Pathol (1999) 2.73
Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci U S A (2001) 2.52
MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev (2001) 2.48
JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev (1998) 2.29
Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood (1996) 2.12
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia (2007) 2.03
Requirement of the JIP1 scaffold protein for stress-induced JNK activation. Genes Dev (2001) 1.96
DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia (2008) 1.70
Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines. Cancer Genet Cytogenet (2000) 1.59
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies. J Clin Oncol (1996) 1.53
Obtaining clone-specific primer and probe for the immunoglobulin heavy-chain gene from paraffin-embedded tissue of B-cell lymphoma: technical considerations. Diagn Mol Pathol (1997) 1.48
Clonality analysis of B-lymphoid proliferations using the polymerase chain reaction. Cancer (1996) 1.47
Lymphomas with follicular and monocytoid B-cell components. Evidence for a common clonal origin from follicle center cells. Am J Clin Pathol (2000) 1.40
Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood (2000) 1.39
t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol (1997) 1.39
Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. J Infect Dis (2001) 1.30
p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis. Oncogene (2009) 1.29
Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am J Hematol (2000) 1.26
Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev (1998) 1.24
Isolated elevation of serum alkaline phosphatase and biliary disease in the elderly. Postgrad Med J (1982) 1.21
Retroviral-mediated gene transfer of human ornithine transcarbamylase into primary hepatocytes of spf and spf-ash mice. Hum Gene Ther (1992) 1.19
An efficient method for the extraction of DNA from formalin-fixed, paraffin-embedded tissue by sonication. Biotechniques (1991) 1.18
Targeting of hexokinase 1 to liver and hepatoma mitochondria. Proc Natl Acad Sci U S A (1992) 1.17
Hodgkin's disease. Cancer (1995) 1.16
Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. J Clin Oncol (1999) 1.13
Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Hum Pathol (1998) 1.08
Autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Biol Blood Marrow Transplant (2000) 1.06
Primary extramedullary plasmacytoma in the atria of the heart. Cardiovasc Pathol (2001) 1.02
Mtbp haploinsufficiency in mice increases tumor metastasis. Oncogene (2007) 1.02
A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1). Clin Exp Immunol (2005) 0.99
Construction of a 1.2-Mb contig surrounding, and molecular analysis of, the human CREB-binding protein (CBP/CREBBP) gene on chromosome 16p13.3. Genomics (1997) 0.98
Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases. Bone Marrow Transplant (1998) 0.96
Decreased Mdm2 expression inhibits tumor development induced by loss of ARF. Oncogene (2006) 0.93
E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation. Oncogene (2001) 0.92
Cytomegalovirus detection in bone marrow transplant patients with idiopathic pneumonitis. A clinicopathologic study of the clinical utility of the polymerase chain reaction on open lung biopsy specimen tissue. Am J Clin Pathol (1991) 0.91
Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage. Blood (1995) 0.91
Image sharpness measurement in the scanning electron-microscope--part III. Scanning (1999) 0.90
Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders. Lab Invest (1996) 0.90
A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis. Oncogene (2010) 0.90
Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features. Am J Clin Pathol (1997) 0.89
Autoregulation of adenovirus E1A gene expression. J Virol (1986) 0.89
Dorsal pancreas presenting as a mass in the chest. AJR Am J Roentgenol (1987) 0.89
Aging mice have increased chromosome instability that is exacerbated by elevated Mdm2 expression. Oncogene (2011) 0.89
Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma. Leuk Lymphoma (2000) 0.87
Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis. Cell Death Differ (2012) 0.87
Hodgkin's disease following solid organ transplantation. Ann Oncol (1996) 0.86
Multicentric angiofollicular lymph node hyperplasia in children: a clinicopathologic study of eight patients. Mod Pathol (1996) 0.85
The expression and localization of membrane type-1 matrix metalloproteinase in human abdominal aortic aneurysms. J Vasc Surg (2001) 0.85
High-resolution analysis of immunoglobulin heavy-chain gene rearrangements using denaturing gradient gel electrophoresis. Diagn Mol Pathol (1996) 0.85
Fibrin sealant as a plug for the post liver biopsy needle track. Clin Radiol (1989) 0.85
Mapping of a new MAP kinase activated protein kinase gene (3PK) to human chromosome band 3p21.2 and ordering of 3PK and two cosmid markers in the 3p22-p21 tumour-suppressor region by two-colour fluorescence in situ hybridization. Chromosome Res (1996) 0.85
Relationships of bovine leukemia virus prevalence in dairy herds and density of dairy cattle to human lymphocytic leukemia. Am J Vet Res (1987) 0.83
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma. Blood (1996) 0.83
Treatment of post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation with low-dose chemotherapy. Ann Oncol (1998) 0.82
Stimulus-dependent subcellular localization of activated protein kinase C; a study with acidic fibroblast growth factor and transforming growth factor-beta 1 in cardiac myocytes. J Mol Cell Cardiol (1995) 0.82
Factors relating to the development of hypertension after cardiopulmonary bypass. Br Heart J (1985) 0.82
Detection of tumor contamination of peripheral stem cells in patients with lymphoma using cell culture and polymerase chain reaction technology. J Hematother (1994) 0.82
Percutaneous interventional uroradiology. Br J Radiol (1989) 0.81
Diagnosis of lymphomas by the polymerase chain reaction. Am J Clin Pathol (1994) 0.81
Aggressive natural killer cell lymphoma of the small intestine. Mod Pathol (1995) 0.80
Genetic markers associated with progression in early mycosis fungoides. J Eur Acad Dermatol Venereol (2013) 0.80
Gene therapy: a new approach for the treatment of genetic disorders. Clin Pharmacol Ther (1990) 0.80
Clinical importance of genomic imbalances in synovial sarcoma evaluated by comparative genomic hybridization. Cancer Genet Cytogenet (1999) 0.80
Improved ligation-anchored PCR strategy for identification of 5' ends of transcripts. Biotechniques (1996) 0.80
Concurrent lymphocyte predominance Hodgkin's disease and T-cell lymphoma. A report of three cases. Am J Surg Pathol (1996) 0.79
Molecular detection and correction of ornithine transcarbamylase deficiency. Trends Genet (1990) 0.78
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells. Leuk Lymphoma (2001) 0.78
Assignment of the ARHA and GPX1 genes to human chromosome bands 3p21.3 by in situ hybridization and with somatic cell hybrids. Cytogenet Cell Genet (1997) 0.77
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion. Ann Oncol (2011) 0.77
Localization of the pig gene ESD to chromosome 13 by in situ hybridization. Mamm Genome (1992) 0.77
Assessment of inequality in length of the lower limb. Radiography (1987) 0.77
Functional diversity of E1A gene autoregulation among human adenoviruses. J Virol (1992) 0.76
Status epilepticus, hypothermia and metabolic chaos in a man with agenesis of the corpus callosum. J Neurol Neurosurg Psychiatry (1985) 0.75
A useful projection in radiography of the shoulder. J Bone Joint Surg Br (1987) 0.75
Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma. J Clin Oncol (1998) 0.75
Gene therapy in man and mice: adenosine deaminase deficiency, ornithine transcarbamylase deficiency, and Duchenne muscular dystrophy. Adv Exp Med Biol (1991) 0.75
Phenotypic determinants of adenovirus E1A gene autoregulation: variable region between conserved coding domains 2 and 3. Virology (1995) 0.75
Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders. Lab Invest (1997) 0.75
Alaska cares goes to Romania. Alaska Med (1992) 0.75
The drainage of pancreatic fluid collections. Clin Radiol (1991) 0.75
The detection of minimal lymphoma by molecular and combined culture-molecular methods. Br J Haematol (1997) 0.75
Localization of the tryptophanyl tRNA synthetase gene (WARS) on human and bovine chromosomes by in situ hybridization. Mamm Genome (1993) 0.75
'Anoddia'. Clin Radiol (1991) 0.75